AGI.do

Products

What will AGI do for Bilastine?

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PA1123N395. European Medicines Agency schedules Bilastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37845. Bilastine generally arises in the molecular formula C28H37N3O3. The term BILASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 3, 2000, list 44.) Most nations schedule bilastine under HS 29333999 and SITC 51574. As of Q4 2014, BILASTINE remains the US FDA Preferred Term for this commodity. Bilastine bears US NLM identifiers UMLS ID C1101148 and NCI Concept Code C73045. SMILES: O(CCN1C(NC2C1CCCC2)C1CCN(CC1)CCC1CCC(C(C)(C)C(=O)O)CC1)CC.

How AGI delivers it

Four ways AGI delivers for Bilastine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bilastine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bilastine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bilastine connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Particle Size Distributionmodel
  • Residual Solventmodel

Go deeper

Explore Bilastine

Read the deeper take on agi.asView as markdown